Alpha Tau files Q3 2025 results press release

Alpha Tau Medical Ltd. filed a Form 6-K to furnish a press release titled “Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update,” dated November 20, 2025.

Accepted by SEC EDGAR 11/20/2025 - 04:07 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

6-K

Rhea-AI Filing Summary

Alpha Tau Medical Ltd. filed a Form 6-K to furnish a press release titled “Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update,” dated November 20, 2025. The report incorporates this press release by reference into the company’s existing Form F-3 and Form S-8 registration statements.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Alpha Tau Medical Ltd. (DRTS) file in this Form 6-K?

Alpha Tau Medical Ltd. filed a Form 6-K to furnish a press release. The release is titled “Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update” and is attached as Exhibit 99.1, making it part of the public disclosure record.

What is the date of Alpha Tau Medical Ltd.’s Q3 2025 press release in this filing?

The press release attached to the Form 6-K is dated November 20, 2025. This same date appears on the Form 6-K signature page, indicating when the company formally submitted the report through its Chief Executive Officer, Uzi Sofer.

How is this Alpha Tau Medical Ltd. (DRTS) Form 6-K used in relation to other registrations?

The Form 6-K and its exhibits are incorporated by reference into Alpha Tau’s Form F-3 and Form S-8 registration statements. This means the information in the press release becomes legally part of those registration statements for disclosure purposes.

Which registration statements are updated by this Alpha Tau Medical Ltd. Form 6-K?

The filing incorporates the press release into Alpha Tau’s Form F-3 registrations with file numbers 333-271073, 333-264306, 333-274457 and 333-288240, and Form S-8 registrations with file numbers 333-264169, 333-270406, 333-277733 and 333-285745.

Who signed the November 2025 Form 6-K for Alpha Tau Medical Ltd. (DRTS)?

The Form 6-K was signed on behalf of Alpha Tau Medical Ltd. by Uzi Sofer. He signed in his capacity as Chief Executive Officer on November 20, 2025, satisfying the signature requirements under the Securities Exchange Act of 1934.

What exhibit is included with Alpha Tau Medical Ltd.’s November 2025 Form 6-K?

The Form 6-K includes one exhibit, labeled 99.1, which is the press release dated November 20, 2025. That press release contains Alpha Tau’s third quarter 2025 financial results and a corporate update, though its detailed contents are in the exhibit itself.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO SECTION 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2025

Commission File Number: 001-41316

Alpha Tau Medical Ltd.

(Exact Name of Registrant as Specified in Its Charter)

Kiryat HaMada St. 5

Jerusalem, Israel 9777605

+972 (3) 577-4115

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

CONTENTS

On November 20, 2025, Alpha Tau Medical Ltd. (the “Company”) issued a press release titled “Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update.” A copy of this press release is attached to this Form 6-K as Exhibit 99.1.

This Report and the related exhibits are incorporated by reference into the registrant’s Registration Statements on Form F-3 (File Nos. 333-271073, 333-264306, 333-274457 and 333-288240) and Form S-8 (File Nos. 333-264169, 333-270406, 333-277733 and 333-285745).

EXHIBIT INDEX

Exhibit No.		Description
99.1		Press Release dated November 20, 2025

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Alpha Tau Medical Ltd.

Date: November 20, 2025	By:	/s/ Uzi Sofer
		Uzi Sofer
		Chief Executive Officer

Source: View Original Filing on SEC EDGAR